Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$42.05 - $47.77 $1.33 Million - $1.51 Million
31,669 Added 86.1%
68,452 $3.04 Million
Q1 2022

May 16, 2022

BUY
$40.23 - $47.74 $1.48 Million - $1.76 Million
36,783 New
36,783 $1.6 Million
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $244,687 - $272,253
-6,308 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$36.52 - $41.46 $9,093 - $10,323
-249 Reduced 3.8%
6,308 $251,000
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $558,224 - $651,722
-16,289 Reduced 71.3%
6,557 $234,000
Q4 2020

Feb 11, 2021

BUY
$34.07 - $39.94 $68 - $79
2 Added 0.01%
22,846 $841,000
Q3 2020

Nov 10, 2020

SELL
$38.11 - $42.99 $97,523 - $110,011
-2,559 Reduced 10.07%
22,844 $860,000
Q2 2020

Aug 10, 2020

BUY
$37.87 - $43.58 $150,154 - $172,794
3,965 Added 18.5%
25,403 $1.04 Million
Q1 2020

May 12, 2020

SELL
$32.47 - $48.83 $38,152 - $57,375
-1,175 Reduced 5.2%
21,438 $942,000
Q4 2019

Jan 24, 2020

SELL
$42.0 - $48.25 $106,848 - $122,748
-2,544 Reduced 10.11%
22,613 $1.06 Million
Q3 2019

Nov 05, 2019

SELL
$40.46 - $43.52 $57,776 - $62,146
-1,428 Reduced 5.37%
25,157 $1.07 Million
Q2 2019

Jul 18, 2019

SELL
$39.4 - $42.7 $79,391 - $86,040
-2,015 Reduced 7.05%
26,585 $1.06 Million
Q1 2019

Apr 18, 2019

SELL
$38.57 - $42.69 $333,051 - $368,628
-8,635 Reduced 23.19%
28,600 $1.2 Million
Q4 2018

Jan 25, 2019

SELL
$37.8 - $42.69 $170,780 - $192,873
-4,518 Reduced 10.82%
37,235 $1.42 Million
Q3 2018

Oct 17, 2018

SELL
$39.75 - $42.69 $26,235 - $28,175
-660 Reduced 1.56%
41,753 $1.68 Million
Q2 2018

Jul 27, 2018

BUY
$39.61 - $42.76 $326,861 - $352,855
8,252 Added 24.16%
42,413 $1.71 Million
Q1 2018

Apr 06, 2018

BUY
$36.18 - $40.15 $195,046 - $216,448
5,391 Added 18.74%
34,161 $1.34 Million
Q4 2017

Jan 25, 2018

BUY
$35.34 - $41.9 $28,272 - $33,520
800 Added 2.86%
28,770 $1.02 Million
Q3 2017

Oct 03, 2017

BUY
$39.44 - $41.55 $1.1 Million - $1.16 Million
27,970
27,970 $1.14 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.